Altasciences Acquires WCCT Global
Laval, Quebec, February 19, 2021 – Altasciences announced today that they have acquired WCCT Global, Inc., an early stage clinical research organization, or CRO, located in Southern California on the U.S.A.’s West Coast. This acquisition will complement Altasciences’ current clinical operations in Montreal, Canada, and Kansas City, U.S.A., while being in close proximity to their Washington State preclinical facility.
“This acquisition expands Altasciences’ footprint by providing Phase I and II clinical pharmacology services on the West Coast, and adds 180 beds to our current 400-bed offering. Furthermore, it allows us to enhance our capabilities with expertise in ethnobridging and other specialty areas for hard-to-recruit study populations,” added Steve Mason, Co-Chief Operating Officer, at Altasciences.
The transaction was completed on February 12.
“This acquisition is an integral part of Altasciences’ strategic growth plan to provide a comprehensive, fully integrated early phase drug development solution to address the ever-changing outsourcing challenges of biopharmaceutical companies across the globe. We look forward to working side by side with our new team of clinical experts in California, a team that shares our values for excellence, quality, and customer focus,” explained Chris Perkin, CEO at Altasciences.
WCCT Global was founded in 1998 and has conducted over 600 Phase I studies – an area it specializes in – out of over 1,000 Phase I-IV studies the company has conducted to date.
“Joining the Altasciences team will enhance our offering while allowing us to continue the responsive delivery of quality research data to our global biopharmaceutical clients,” stated Gregory Hanson, Executive Chairman, WCCT Global.
Altasciences is a mid-size CRO/CDMO offering pharmaceutical and biotechnology companies a proven, flexible approach to preclinical and clinical pharmacology studies, including formulation, manufacturing, and analytical services. For over 25 years, Altasciences has been partnering with sponsors to help support educated, faster, and more complete early drug development decisions. Altasciences’ integrated, full-service solutions include preclinical safety testing, clinical pharmacology and proof of concept, bioanalysis, program management, medical writing, biostatistics, clinical monitoring, and data management, all customizable to specific sponsor requirements. Altasciences helps sponsors get better drugs to the people who need them, faster.
CONTACT:
Julie-Ann Cabana
Altasciences
514 601-9763
jcabana@altasciences.com
Formulation Development Services
Altasciences offers extensive and comprehensive formulation development services for your preclinical toxicology programs.
Our Analytical Chemistry experts regularly develop a vast array of formulation types (for both oral and parenteral administration) and offer a comprehensive package of formulation development from preformulation investigations, formulation validations, stability assessments, compatibility (e.g., with filters and catheters), and assessment of suitability with dosing apparatus. A combination of our formulation expertise, knowledge of vehicle suitability in preclinical models and close collaboration with our toxicologists ensures the development of a vast array of formulation types suitable for preclinical programs.
Oral
- Solutions
- Suspensions
- Emulsions
- Pills
Parenteral
- Intravenous (bolus and continuous)
- Subcutaneous
- Intraperitoneal
- Intramuscular
- Intravitreal
Download our one-pager to learn more.
Contact our scientists for a customized experience.
Altasciences transforms the traditional outsourcing paradigm by simplifying and streamlining solutions, whether a single study or multiple programs, to offer an integrated/synchronized approach to CRO and CDMO services from lead candidate selection to clinical proof of concept, and beyond.
You may also be interested in the following:
Fact Sheet:
Altasciences and Sygnature Discovery Join Forces for New Webinar Series
IND Planning Resources to Get You There Faster
We are ideally positioned to support an efficient, rapid, IND submission to the FDA — for a review of the IND requirements, consult our Preclinical Assessment Planning Guide. Your submission needs to contain comprehensive information in three critical areas:
- Animal pharmacology and toxicology studies
- Manufacturing for producing the drug substance and the drug product
- Detailed protocols for proposed early clinical studies, including clinical investigators, necessary documentation and reviews, all within IND regulations
Altasciences’ Proactive Drug Development platform seamlessly integrates all of these key services, preclinical, manufacturing and early phase clinical, within an integrated partnership.
Altasciences transforms the traditional outsourcing paradigm by simplifying and streamlining solutions, whether a single study or multiple programs, to offer an integrated/synchronized approach to CRO and CDMO services from lead candidate selection to clinical proof of concept.
You may also be interested in the following:
- Video: Preclinical Services
- The Altascientist: Safety Pharmacology Studies – a Review
- Fact Sheets:
Rapid Turnaround Medical Writing Solutions
Reliable and Robust Medical Writing Solutions
Altasciences’ expert writing services are offered as an integrated part of your study (or studies) or as a standalone service.
From design to final regulatory submission, we provide a range of writing solutions to ensure quality documentation for your clinical trials. We produce flexible, efficient processes for both small and large projects, and are able to expedite your request as needed. To meet global technical and regulatory requirements, we apply best practices for content, format, and style to in-house or sponsor-supplied document templates.
Contact our team of experts to learn more about our medical writing capabilities.
Altasciences transforms the traditional outsourcing paradigm by simplifying and streamlining solutions, whether a single study or multiple programs, to offer an integrated/synchronized approach to CRO and CDMO services from lead candidate selection to clinical proof of concept and beyond.
You may also be interested in the following:
Fact sheet: Integrated Research Support Services
Webpage: Full-Time Equivalent (FTE) Capabilities
Webpage: Complementary CRO Research Services
Webpage: Comprehensive Clinical Trial Services
Providing you with Cost-Saving and Quality Liquid-Filled Capsule Solutions
Our state-of-the-art equipment train and highly trained operators ensures that we can successfully deliver your liquid-filled capsule projects – simple or complex, large or small scale.
In this short video, our Vice President of Manufacturing, brings you inside our 30,000‑square‑foot, purpose-built, FDA‑inspected cGMP facility to provide you with a preview of our liquid-filled capsule manufacturing suite in Philadelphia, PA.
Contact us today for access to our full CDMO virtual facility tour video.
You may also be interested in the following:
January 2021
Most Promising Biotech Consulting Services Company